News and Trends 3 Oct 2024
Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.
Don't miss out on the next big biotech breakthrough
Get all the latest updates straight into your inbox!
Newsletter Signup - Home CTA
"*" indicates required fields
-
In DepthOctober 7, 2024Spinal cord injury: Are we getting closer to a treatment?
-
In DepthOctober 4, 2024The biggest private biotech investments in September 2024
-
PodcastOctober 4, 2024Targeting telomerase to disrupt cancer
-
Best in BiotechOctober 3, 2024Six biotechs driving progress in Duchenne muscular dystrophy
- Latest Posts
- Popular Posts
News and Trends 2 Oct 2024Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder
Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.
Best in Biotech 1 Oct 2024Lithuania’s biotech: Six companies to put on your radar
Here are six companies at the forefront of Lithuania’s growing biotech scene, showcasing innovations in protein engineering and gene editing.
Sublingual delivery of GLP-1 receptor agonists
Discover how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual delivery method.
News and Trends 30 Sep 2024The race for a bird flu vaccine: milestones and breakthroughs
The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.
News and Trends 27 Sep 2024Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders
Italian startup Aptadir Therapeutics has launched with $1.6 million to bring a new class of drugs to the clinic and a technology to be reckoned with.ADVERTISEMENT
ADVERTISEMENT
Podcast 27 Sep 2024Harnessing the body’s natural targeted protein degradation system to treat diseases
Listen to our conversation with Andrew Hirsch, CEO at C4 Therapeutics, a leader in the targeted protein degradation field.
In Depth 26 Sep 2024The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond
Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation.
Best in Biotech 26 Sep 2024Europe’s rising biotech stars: 10 startups to watch in 2024
The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash.
In Depth 25 Sep 2024How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market
Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s.
Reports 25 Sep 2024Current trends & innovations in 3D organoids
Discover how 3D organoids are already shaping research & drug development today and explore their future potential Dive into our report and… More about this report: The market for advanced cell models is booming and expected to grow from $1.42 billion in 2022 to $5.29 billion by 2032. This surge is driven by the unique […]
In Depth 24 Sep 2024New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster
Discover how the recent Pfizer-Flagship alliance model sets a trend in pharma-VC partnerships, fostering innovation in drug development.
Expert Advice 2 Feb 20245 biotech career paths where demand is skyrocketing
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.
Best in Biotech 12 Mar 2024The twelve hottest biotech companies in the Boston area
Explore Boston’s vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.
In Depth 12 Feb 2024RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?
Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time.
In Depth 15 Jan 2024The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
In Depth 8 Feb 2024Could we see a new dawn for hair loss treatments?
Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.
Best in Biotech 5 Jan 2024Five AI drug discovery companies you should know about
Take a look at five of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
Expert Advice 15 Mar 2024Is biotechnology a good career? Here are the pros and cons
Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles.
In Depth 9 Feb 2024Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
Podcast 19 Jan 2024Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
Best in Biotech 12 Apr 20246 biotechnology universities in the US nurturing tomorrow’s trailblazers
Discover the top biotechnology universities in the US offering cutting-edge programs that are helping students find a career in biotech.
In Depth 8 Jul 2024Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
Best in Biotech 13 Feb 2024Eight biotechs thriving in Seattle
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
ADVERTISEMENT